When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Meningioma

  • Overview
  • Theory
  • Diagnosis
  • Management
  • Follow up
  • Resources
Last reviewed: 20 Aug 2025
Last updated: 11 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • cefaleia
  • deficit neurológico
  • convulsão
Full details

Other diagnostic factors

  • deficit cognitivo
  • vertigens/tonturas
Full details

Risk factors

  • radiação ionizante
  • predisposição genética
  • hormônios: endógenos ou exógenos
  • trauma cranioencefálico
Full details

Diagnostic tests

1st tests to order

  • RNM cranioencefálica ou da coluna com e sem contraste
Full details

Tests to consider

  • TC cranioencefálica ou da coluna vertebral
  • PET/TC com receptores da somatostatina
  • angiografia cerebral
  • histopatologia de ressecção cirúrgica
Full details

Treatment algorithm

ACUTE

bom candidato cirúrgico

não candidato à cirurgia

ONGOING

tumor recorrente ou progressivo após o tratamento inicial

Contributors

Authors

Stephen T. Magill, MD, PhD

Assistant Professor

Lou and Jean Malnati Brain Tumor Institute

Robert Lurie Comprehensive Cancer Center

Department of Neurological Surgery

Northwestern University Feinberg School of Medicine

Chicago

IL

Disclosures

STM has authored several articles cited in this topic.

Acknowledgements

Dr Stephen T. Magill would like to gratefully acknowledge Professor William T. Couldwell and Dr Jayson A. Neil, previous contributors to this topic.

Disclosures

WTC is an author of several references cited in this topic. JAN declares that he has no competing interests.

Peer reviewers

Marc Chamberlain, MD

Professor of Neurology

Moffitt Cancer Center and Research Institute

University of Washington

Seattle

WA

Disclosures

MC is an author of several references cited in this topic.

Ian McCutcheon, MD

Professor of Neurosurgery

The University of Texas M. D. Anderson Cancer Center

Houston

TX

Disclosures

IM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

World Health Organization Classification of Tumours Editorial Board. WHO classification of tumours of the central nervous system. 5th Edition. France: IARC; 2021.

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51.Full text  Abstract

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: central nervous system cancers [internet publication].Full text

Goldbrunner R, Stavrinou P, Jenkinson MD, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021 Nov 2;23(11):1821-34.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer